SILCOPHL fundamentals
An in-depth look to SILCO PHARMACEUTICALS LTD operating, investing, and financing activities
SILCOPHL free cash flow for Q3 24 is 11.32 M BDT. For 2023, SILCOPHL free cash flow was -1.47 M BDT and operating cash flow was 180.48 M BDT.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BDT
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM